Vivace Insurance Partners Launches in the Americas, Rebrands in Asia Pacific
+8 Partners ecosystem MGA company focused on marine and logistics expands international operations
Deriving its name from the musical expression denoting freshness, energy and movement, Vivace is focused on fusing bespoke coverage solutions with intelligence and data gained from a years-long focus on a global logistics industry client base.
Vivace
Vivace
Leading the company will be Rebekah Khew, director –
Vivace's MGA software platform "Vivacity©" provides seamless interactivity across all underwriting functions, accounting, online engagement with clients and principals, and granular, AI-enabled intelligent reporting. Developed over many years of incremental learning from a logistics industry client base, it gives brokers a quick and easy route to quotes and policy management.
"Vivace is a focused, specialized MGA with in-depth knowledge and understanding of key players, risk exposures and the cultural nuances of our markets. Under the leadership of Cordell and Rebekah, the company offers a fresh approach with experienced players writing insurance online on behalf of the best security in the business," said
"Vivace is the perfect combination of technological innovation backed by a relationship-driven approach to business. I'm excited to be a part of the team of seasoned industry professionals with a forward-thinking mindset," said Fenig.
"Brokers and clients need to be confident that their underwriting partner is committed to supporting their business over the long term. And it's clear that Vivace delivers," said Khew.
About
For more information, please visit
About
Headquartered in
For more information, please visit +8 Partners.
Media Contact
[email protected]
(312) 213-6233
View original content to download multimedia:https://www.prnewswire.com/news-releases/vivace-insurance-partners-launches-in-the-americas-rebrands-in-asia-pacific-302086708.html
SOURCE


Provell Pharmaceuticals and Mark Cuban Cost Plus Drug Company Bring Leading Hypothyroid Drug, Euthyrox®, to U.S. Patients at Low-Cost Prices through Direct-to-Consumer Model
Ian Clark
Advisor News
- Global economic growth will moderate as the labor force shrinks
- Estate planning during the great wealth transfer
- Main Street families need trusted financial guidance to navigate the new Trump Accounts
- Are the holidays a good time to have a long-term care conversation?
- Gen X unsure whether they can catch up with retirement saving
More Advisor NewsAnnuity News
- Prudential launches FlexGuard 2.0 RILA
- Lincoln Financial Introduces First Capital Group ETF Strategy for Fixed Indexed Annuities
- Iowa defends Athene pension risk transfer deal in Lockheed Martin lawsuit
- Pension buy-in sales up, PRT sales down in mixed Q3, LIMRA reports
- Life insurance and annuities: Reassuring ‘tired’ clients in 2026
More Annuity NewsHealth/Employee Benefits News
Life Insurance News
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on Malaysia’s Non-Life Insurance Segment
- Report Summarizes Kinase Inhibitors Study Findings from Saga University Hospital (Simulation of Perioperative Ibrutinib Withdrawal Using a Population Pharmacokinetic Model and Sparse Clinical Concentration Data): Drugs and Therapies – Kinase Inhibitors
- Flawed Social Security death data puts life insurance benefits at risk
- EIOPA FLAGS FINANCIAL STABILITY RISKS RELATED TO PRIVATE CREDIT, A WEAKENING DOLLAR AND GLOBAL INTERCONNECTEDNESS
- Envela partnership expands agent toolkit with health screenings
More Life Insurance News